A Harvard-trained lawyer who later became the first Black man to serve as CEO of a major pharmaceutical company has joined the 13-person governing board of Harvard University, which is still reeling from accusations that it failed to condemn calls for the genocide of Jews.

Kenneth Frazier, who was general counsel of Merck before serving as CEO from 2011 to 2021,  will fill a vacant seat on the board as it grapples with reputational damage and boycotts by a number of financial donors accusing the school of going soft on antisemitism. One sign of that discontent was a sharp drop in early undergraduate applications.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]